Lenvatinib for Advanced Bone and Soft Tissue Sarcoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
EffectivenessSexuality
Interventions
DRUG

Lenvatinib mesylate capsule

Lenvatinib mesylate capsule, 8mg (body weight ≤60kg) or 12mg (body weight \>60kg), orally, once daily. Take the medicine about half an hour after meals (the time of taking the medicine should be the same as possible every day) and take it with warm water.

Trial Locations (1)

Unknown

RECRUITING

Department of Bone and Soft Tissue ,Henan Cancer Hospital, Zhengzhou

All Listed Sponsors
lead

Henan Cancer Hospital

OTHER_GOV